Shionogi Inc Drug Patent Portfolio
Shionogi Inc owns 4 orange book drugs protected by 11 US patents Given below is the list of Shionogi Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10004750 | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof | 03 Sep, 2035 | Active |
| US9949982 | Preparation containing cephalosporin having a catechol moiety | 03 Sep, 2035 | Active |
| US9238657 | Cephalosporin having catechol group | 14 Nov, 2033 | Active |
| US7294342 | Ectoparasite asphyxiator compositions and methods for their application | 19 May, 2024 | Expired |
| US6793931 | Ectoparasite asphyxiator compositions and methods for their applications | 11 Jul, 2022 | Expired |
| US8247402 | Crystal form of pyrrolidylthiocarbapenem derivative | 30 Mar, 2021 | Expired |
| US6106861 | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth | 05 Dec, 2017 | Expired |
| US5858383 | Methods and compositions for topical treatment of ectoparasites | 11 Aug, 2017 | Expired |
| US6139859 | Methods and compositions for topical treatment of ectoparasites | 11 Aug, 2017 | Expired |
| US5317016 | Pyrrolidylthiocarbapenem derivative | 05 Jun, 2015 | Expired |
| US5464632 | Rapidly disintegratable multiparticular tablet | 22 Mar, 2013 | Expired |
Latest Legal Activities on Shionogi Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Shionogi Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 08 Apr, 2024 | US8247402 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Jul, 2023 | US9238657 |
|
Patent Term Extension Certificate
Critical
| 25 Oct, 2022 | US9238657 |
|
Email Notification
Critical
| 26 Sep, 2022 | US9238657 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Sep, 2022 | US9238657 |
|
Correspondence Address Change
Critical
| 23 Sep, 2022 | US9238657 |
| Notice of Final Determination -Eligible | 14 Jul, 2022 | US9238657 |
|
FDA Final Eligibility Letter
Critical
| 17 Feb, 2022 | US9238657 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 08 Dec, 2021 | US10004750 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Oct, 2021 | US9949982 |
| transaction for FDA Determination of Regulatory Review Period | 30 Jun, 2021 | US9238657 |
| transaction for FDA Determination of Regulatory Review Period | 08 Jun, 2021 | US9238657 |
| Second letter to regulating agency to determine regulatory review period | 06 Apr, 2021 | US9238657 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US9238657 |
| Initial letter Re: PTE Application to regulating agency | 06 Nov, 2020 | US9238657 |
Shionogi Inc's Family Patents
Shionogi Inc Drug List
Given below is the complete list of Shionogi Inc's drugs and the patents protecting them.
1. Doribax
Doribax is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8247402 | Crystal form of pyrrolidylthiocarbapenem derivative |
30 Mar, 2021
(4 years ago)
| Expired |
| US5317016 | Pyrrolidylthiocarbapenem derivative |
05 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Doribax's drug page
2. Fetroja
Fetroja is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10004750 | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof |
03 Sep, 2035
(10 years from now)
| Active |
| US9949982 | Preparation containing cephalosporin having a catechol moiety |
03 Sep, 2035
(10 years from now)
| Active |
| US9238657 | Cephalosporin having catechol group |
14 Nov, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fetroja's drug page
3. Rybix Odt
Rybix Odt is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6106861 | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
05 Dec, 2017
(7 years ago)
| Expired |
| US5464632 | Rapidly disintegratable multiparticular tablet |
22 Mar, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rybix Odt's drug page
4. Ulesfia
Ulesfia is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7294342 | Ectoparasite asphyxiator compositions and methods for their application |
19 May, 2024
(1 year, 11 days ago)
| Expired |
| US6793931 | Ectoparasite asphyxiator compositions and methods for their applications |
11 Jul, 2022
(2 years ago)
| Expired |
| US5858383 | Methods and compositions for topical treatment of ectoparasites |
11 Aug, 2017
(7 years ago)
| Expired |
| US6139859 | Methods and compositions for topical treatment of ectoparasites |
11 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ulesfia's drug page